{
  "id": 1821781,
  "title": "Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?",
  "url": "https://urgent.news/2026/08/18/procept-biorobotics-ceo-buys-23-900-shares-amid-48-stock-decline-what",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-18T22:31:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/procept-biorobotics-ceo-buys-23900-shares-amid-48-stock-decline-what-does-tell-investors"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThe purchase involved 23,900 shares at $20.85 per share, representing an investment of ~$498,000.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?",
        "url": "https://urgent.news/2026/08/18/clarivate-director-cornick-buys-900-000-shares-for-1-7-million-what",
        "published": "2026-08-18T22:51:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}